MedTech Innovation og investeringer fra EU er med at til skabe fremtiden
Medicinske teknologier revolutionerer sundhedsvæsenet og leverer innovative løsninger, der forbedrer diagnose, behandling og patientpleje. Fra banebrydende diagnostiske værktøjer til avanceret kirurgisk udstyr transformerer MedTech innovationer sundhedslandskabet ved at gøre det mere effektivt, præcist og tilgængeligt.
Funding muligheder for MedTech
EU har konsekvent støttet forskning og udvikling inden for MedTech gennem strategiske initiativer og betydelige investeringer på i alt milliarder af euro med det formål at fremme innovation inden for medicinske teknologier.
På trods af streng overholdelse af lovgivningen er forpligtelsen til at fremme sundhedsinnovation fortsat stærkere end nogensinde før. Disse bestræbelser understreger EU's strategiske tilgang til at bevare konkurrenceevnen og drive teknologiske fremskridt inden for sundhedsvæsenet.
Vi kan hjælpe dig
Nordic Innovators har stor erfaring med at arbejde med kunder inden for Life Science indsustrien og kan hjælpe dig med at søge soft funding.
Det kan være at du er aktiv inden for medicinsk udstyr, terapeutik og avancerede diagnostiske projekter såsom:
- Molekylær diagnostik, medicinske billedsystemer og point-of-care udstyr, herunder AI-drevet modeller
- Regenerative medicinske teknologier som vævsteknologi, bio-printing, cellebaserede terapeutik
- Innovative wearables, implanterbare sensorer, sundhedsovervågningssystemer
- Prostetiske implantater, robotkirurgiske anordninger og relaterede produktionssystemer.
Key EU Funding Programmes for Life Science
It gives grants and equity funding to innovative startups and SMEs with high impact/risk products or services. A unique combination of funding from €0.5 to 17.5 million to support innovative, products, services or business models that can create new markets or disrupt existing ones. New application process - 3 main stages.
Aimed for international projects that accelerate marketable innovative products. It is entry point enabling SMEs to merge and share expertise across borders. The consortium must have partners based in at least two different Eurostars countries. Funding average ranges of 50-75% of project costs.
This programme gives funding to turn research results into innovation opportunities. The goal is to help mature the technologies and develop business cases for the future commercialization. This can be in any field of science/technology and deal with specific challenges in various strategic fields.
Both IA and RIA are main vehicles for project-based collaborative technology development supported by the EC. IA is geared towards advancing innovative solutions towards market readiness and RIA is focused on pushing the boundaries of knowledge through pioneering research.
The programme consists of a combination of both open and challenge driven funding. It supports the exploration of bold ideas for radically new technologies and welcomes the high-risk and interdisciplinary cutting-edge science collaborations that underpin technological breakthroughs.
Støtter ambitiøse innovationsideer med klare målsætninger samt vidensbaseret udviklingsprojekter fra danske SMV’er, der øger konkurrenceeven. Innobooster er også relevant, hvis der er behov for ny viden fx gennem et samarbejde med en vidensinstitution eller firma.
innovative health initiative
Innovative health initiative is a EU public-private partnership funding health research and innovation.
Organisations in the EU or Horizon Europe-associated countries including universities, research institutions, SMEs can apply for IHI funding. Larger companies may also qualify based on proposal calls.